Clemastine

BRAND NAMES

• Tavist (commonly used in the United States; clemastine fumarate) 

• Tavegil (widely used in Europe and many other countries)

MECHANISM OF ACTION

Clemastine is a first-generation H1 antihistamine that works by competitively blocking Histamine H1 receptor in the body. By preventing histamine from binding to these receptors, it reduces typical allergic symptoms such as itching, sneezing, runny nose, and watery eyes, which are common in conditions like Allergic Rhinitis. Because it readily crosses the blood–brain barrier, it also causes sedation as a common side effect.

PHARMACOKINETICS

Absorption

Clemastine is well absorbed from the gastrointestinal tract after oral administration. However, it undergoes significant first-pass metabolism in the liver, which reduces its systemic availability. Peak plasma levels are usually reached within a few hours, and its lipophilic nature allows it to distribute widely in tissues and cross the blood–brain barrier.

Distribution

Clemastine has a large volume of distribution, typically reported to be around ~10–15 L/kg, indicating extensive tissue distribution beyond the vascular compartment. Due to its high lipophilicity and protein binding, it readily accumulates in tissues, including the central nervous system, which also explains its sedative effects.

Metabolism

Clemastine is extensively metabolized in the liver, mainly through hepatic microsomal enzymes (including the cytochrome P450 system). It undergoes processes such as N-demethylation and oxidation to form inactive metabolites. Because of this significant first-pass hepatic metabolism, only a fraction of the administered dose reaches systemic circulation in active form, and its metabolites are primarily eliminated via renal excretion.

Elimination

Clemastine is eliminated mainly through the kidneys after hepatic metabolism. Its metabolites are excreted in urine, with only a small amount of unchanged drug appearing in the urine. It has a relatively long elimination half-life (about 12–24 hours), which supports twice-daily dosing and contributes to its prolonged antihistamine and sedative effects.

PHARMACODYNAMICS

Clemastine is a first-generation H1 antihistamine that works as a competitive inverse agonist at Histamine H1 receptor. By blocking histamine action, it reduces allergic symptoms such as sneezing, itching, and runny nose in conditions like Allergic Rhinitis. It also crosses the blood–brain barrier, producing sedative effects, and has mild anticholinergic activity. 

ADMINISTRATION

Clemastine is most commonly administered orally in tablet or syrup form, usually taken once or twice daily depending on symptom severity. It can be taken with or without food, though taking it with food may help reduce gastric irritation in some patients. Because it causes sedation, it is often recommended to take doses in the evening or at bedtime to minimize daytime drowsiness. 

DOSAGE AND STRENGTH 

Clemastine is commonly available in 1 mg tablets (clemastine fumarate) and sometimes in syrup formulations (typically 0.5 mg/5 mL or similar, depending on country). The usual adult dose is 1 mg twice daily, though dosing may be adjusted based on symptom severity and patient response. Lower or weight-based doses are used in children, and it should always be taken under medical guidance due to its sedative effects.

 DRUG INTERACTIONS 

Clemastine interacts with other CNS depressants like alcohol, benzodiazepines, and opioids, increasing sedation and drowsiness. It may also have additive anticholinergic effects with drugs such as tricyclic antidepressants, leading to dry mouth, blurred vision, and constipation.

 FOOD INTERACTIONS

 Clemastine has minimal direct food interactions, but taking it with alcohol should be avoided as it can significantly increase drowsiness and central nervous system depression. Food does not notably affect its absorption, so it can be taken with or without meals, though taking it with food may help reduce stomach discomfort in some people.

 CONTRAINDICATIONS

 Clemastine is contraindicated in hypersensitivity to the drug and should be avoided in narrow-angle glaucoma, severe asthma, and urinary retention or prostatic hypertrophy due to its anticholinergic effects. Caution is advised in the elderly because of increased risk of sedation and confusion.

 SIDE EFFECTS 

• Dizziness

• Dry mouth

• Blurred vision

• Constipation

• Nausea 

• Urinary retention 

• Confusion (especially in elderly) 

OVER DOSE 

• Dry mouth and severe anticholinergic effects

• Dilated pupils (mydriasis)

• Seizures (in severe cases)

• Respiratory depression in extreme overdose

 TOXICITY

 Clemastine toxicity includes severe sedation, anticholinergic effects (dry mouth, urinary retention, blurred vision), confusion or hallucinations, tachycardia, seizures, and respiratory depression in severe cases. Management is mainly supportive with close monitoring.